E Gaffal,J Tietze
E Gaffal
Carolina Laetitia Fiederer,Stephan Forchhammer,Martin Schaller et al.
Carolina Laetitia Fiederer et al.
Julia K Tietze
Julia K Tietze
Melanoma is a highly immunogenic cancer with an increased infiltration of lymphocytes (TIL). TIL are a very heterogeneous population which consists among others of CD8+ T cells, CD4+ T cells, regulatory T cells, B cells, and natural killer ...
[Melanoma-associated macrophages-from molecular signals to therapeutic application] [0.03%]
与黑色素瘤相关的巨噬细胞-从分子信号到治疗应用
Eftychia Chatziioannou,Serra Atilla Aydin,Stephan Forchhammer et al.
Eftychia Chatziioannou et al.
Background: Macrophages are an important component of the innate immune system. They are abbreviated as Mφ, MΦ, or MP. The name is derived from Greek: large eaters, μακρóς (makrós) = large, φαγεῖν (phagein)...
Judith Sirokay,Cornelia Mauch
Judith Sirokay
Background: A considerable proportion of patients with advanced melanoma succumb to metastatic disease despite the initial success of modern therapies. Ob...
[Eosinophilic dermatoses] [0.03%]
[嗜酸性皮肤病]
E Papakonstantinou,J Fischer,M M Limberg et al.
E Papakonstantinou et al.
Eosinophilic dermatoses are a heterogeneous group of rare diseases that histopathologically display the defining pattern of an eosinophil-rich dermal infiltrate. In these eosinophilic dermatoses, a histopathologic pattern called flame figur...
[Complications and their management in the surgical treatment of lipohyperplasia dolorosa] [0.03%]
脂肥大性疼痛症手术治疗的并发症及处理
Matthias Gensior,Manuel Cornely
Matthias Gensior
Background: There are both conservative and surgical treatment options for lipohyperplasia dolorosa (LiDo). A procedure that has been established since 1997 is the surgical treatment through lymphological liposculpture ac...
[Immunological mechanisms of cognitive dysfunction under systemic therapy in metastatic melanoma] [0.03%]
系统治疗转移性黑色素瘤时认知功能障碍的免疫学机制
Miriam Mengoni,Thomas Tüting,Evelyn Gaffal
Miriam Mengoni
Neurocognitive impairments of memory, speech, and attention can occur in cancer patients as a direct result of the cancer but also in the context of therapy. With the development of modern immunotherapies and their use in combination with s...
Franziska Pahnke,Jörg Tittelbach,Peter Elsner
Franziska Pahnke